July 23, 2020
RPI in Upstate NY did In Cell Studies on Seaweed Extract. Well, It Outperforms Remdesivir in Blocking COVID-19 Virus
Heparin is a common anitcoagulent. Now it could also form basis of a viral trap for SARS-CoV-2
Well folks only in NY folks. In a test of antiviral effectiveness against the virus that causes COVID-19. That’s right an extract from edible seaweeds. For it’s substantially outperforming remdesivir. That’s the current standard antiviral used to combat the disease.
Heparin is a common blood thinner. It’s a heparin variant stripped of its anticoagulant properties. So it performed on par with remdesivir in inhibiting SARS-CoV-2 infection in mammalian cells. So I say: BAM BAM BAM BAM BAM and that’s a Flintstone’s Reference!!
Published in Cell Discovery; for that’s the research document amen and the latest example of a decoy strategy from nasty crap is what they want to say. Yet I’ll do it. Thanks RPI. Appreciate it!
So researchers from the Center for Biotechnology and Interdisciplinary Studies (CBIS) at Rensselear Polytechnic Institute are developing against viruses like the novel coronavirus that spawned the current global health crisis.
The spike protein on the surface of SARS-CoV-2 latches onto the ACE-2 receptor, a molecule on the surface of human cells. Once secured, the virus inserts its own genetic material into the cell, hijacking the cellular machinery to produce replica viruses.
In conclusion and however, the virus could easily be persuaded to lock onto a decoy molecule. One that offers a similar fit. The neutralized virus would be trapped and eventually degrade naturally. Again. Bam bam bam bam bam!!!!